IMPALA MOL-PAP-002 A randomised double blind placebo controlled multicentre clinical trial of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis patients
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Savara Inc.
Start Date
August 21, 2018
End Date
December 17, 2019
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Savara Inc.
Start Date
August 21, 2018
End Date
December 17, 2019